
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging is targeting significant revenue growth in the upcoming years thanks to its strategic shift towards preventive health care with its Nanox.ARC offering, as evidenced by its potential to generate ~$36M in revenue by 2026. Despite reporting a net loss in the recent year, the company has streamlined its manufacturing process and entered into partnerships with established regional players, such as Digital X-Ray Imaging, to accelerate the deployment and support of its imaging platform. However, the success of the company's revenue target will depend on the timing, activations, partner execution, and adoption of its technology, which carries risks such as clinical/regulatory, partnership and financial, commercial, legal and intellectual property, and market share.
Bears say
Nano X Imaging is facing significant challenges in converting distribution agreements into revenue, with a lack of progress on financing and execution adding to the uncertainty. Additionally, the company's reliance on partnerships for market expansion and revenue growth may lead to a prolonged sales cycle. This, combined with risks related to clinical/regulatory, financial, and market share, warrant a negative outlook for the company's stock.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares